首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >New liver cell mutants defective in the endocytic pathway
【24h】

New liver cell mutants defective in the endocytic pathway

机译:内吞途径缺陷的新肝细胞突变体

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To isolate mutant liver cells defective in the endocytic pathway, a selection strategy using toxic ligands for two distinct membrane receptors was utilized. Rare survivors termed trafficking mutants (Trf2-Trf7) were stable and more resistant than the parental HuH-7 cells to both toxin conjugates. They differed from the previously isolated Trf1 HuH-7 mutant as they expressed casein kinase 2 alpha" (CK2 alpha") which is missing from Trf1 cells and which corrects the Trf1 trafficking phenotype. Binding of 125 I-asialoorosomucoid (ASOR) and cell surface expression of asialoglycoprotein receptor (ASGPR) were reduced approximately 20%-60% in Trf2-Trf7 cells compared to parental HuH-7, without a reduction in total cellular ASGPR. Based on I-125-transferrin binding, cell surface transferrin receptor activity was reduced between 13% and 88% in the various mutant cell lines. Distinctive phenotypic traits were identified in the differential resistance of Trf2-Trf7 to a panel of lectins and toxins and to UV light-induced cell death. By following the endocytic uptake and trafficking of Alexa(488)-ASOR, significant differences in endosomal fusion between parental HuH-7 and the Trf mutants became apparent. Unlike parental HuH-7 cells in which the fusion of endosomes into larger vesicles was evident as early as 20 min, ASOR endocytosed into the Trf mutants remained within small vesicles for up to 60 min. Identifying the biochemical and genetic mechanisms underlying these phenotypes should uncover novel and unpredicted protein-protein or protein-lipid interactions that orchestrate specific steps in membrane protein trafficking. (c) 2007 Elsevier B.V. All rights reserved.
机译:为了分离在内吞途径中有缺陷的突变肝细胞,使用了针对两种不同的膜受体使用毒性配体的选择策略。罕见的被称为贩运突变体(Trf2-Trf7)的幸存者比两种亲和的HuH-7细胞对两种毒素结合物都稳定且更具抗性。它们不同于先前分离的Trf1 HuH-7突变体,因为它们表达了酪蛋白激酶2 alpha“(CK2 alpha”),而酪蛋白激酶2 alpha“(CK2 alpha”)从Trf1细胞中缺失,并纠正了Trf1运输表型。与亲本HuH-7相比,Trf2-Trf7细胞中125 I-亚去唾液酸类核糖核酸(ASOR)的结合和去唾液酸糖蛋白受体(ASGPR)的细胞表面表达降低了约20%-60%,而总细胞ASGPR却没有降低。基于I-125-转铁蛋白的结合,在各种突变细胞系中,细胞表面转铁蛋白受体的活性降低了13%至88%。在Trf2-Trf7对一组凝集素和毒素以及对紫外线诱导的细胞死亡的差异抗性中鉴定出独特的表型性状。通过跟踪吞噬和运输Alexa(488)-ASOR,亲本HuH-7和Trf突变体之间的内体融合显着差异变得很明显。不同于亲本的HuH-7细胞,在20分钟之内就已经明显地将内体融合到较大的囊泡中,而被内吞进入Trf突变体的ASOR则在小囊泡中长达60分钟。确定这些表型的生化和遗传机制应揭示新颖的和不可预测的蛋白质-蛋白质或蛋白质-脂质相互作用,这些相互作用可以协调膜蛋白运输中的特定步骤。 (c)2007 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号